Phio Pharmaceuticals - Warrants (21/12/2021) Long Term Debt

Phio Pharmaceuticals - Warrants (21/12/2021) (PHIOW) currently reports a long-term debt of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Phio Pharmaceuticals - Warrants (21/12/2021)'s long-term debt history and peer comparisons.

Phio Pharmaceuticals - Warrants (21/12/2021)'s long-term debt changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Phio Pharmaceuticals - Warrants (21/12/2021) reported $0 in long-term debt as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Phio Pharmaceuticals - Warrants (21/12/2021), and consider following PHIOW for alerts when major investors trade the stock.

Phio Pharmaceuticals - Warrants (21/12/2021) is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PHIOW with unrelated industries.